Recombinant attenuated M.tuberculosis-SIVgag(rAMtb-gag) vaccination primes for SIV-specific CD8 T cell response that are boosted by Ad5-SIVgag in mice

Por Kadayam Ranganathan, U, Larsen, M, Abel, K, Jacobs, WR, Fennelly, G
Publicado em 2012

A recombinant attenuated Mycobacterium tuberculosis-SIV combination vaccine is safe and immunogenic in immunocompromised, SIV-infected infant macaques

Por Jensen, K, Ranganathan, UD, Kozlowski, P, Van Rompay, K, Canfield, D, Ravindran, R, Khan, I, Luciw, P, Fennelly, G, Larsen, M, Abel, K
Publicado em 2012